1-1 of 1
Mohammed Yasar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety, Efficacy and Total Cost of Therapy of Decentralized, Point-of-Care Manufactured Anti-CD19 CAR-T Cells for Relapsed or Refractory B Cell Leukemia and Lymphoma: Results from the First Phase 1 Indian Trial (VELCART)

Palani Hamenth Kumar, Arun Kumar Arunachalam, Mohammed Yasar, Phaneendra Venkateswara Rao Datari, Uday Kulkarni, Sushil Selvarajan, Anu Korula, Aby Abraham, Biju George, Vikram Mathews
Journal: Blood
Blood (2024) 144 (Supplement 1): 2090.
https://doi.org/10.1182/blood-2024-201902
Published: 2024